You need to enable JavaScript to run this app.
FDA issues draft guidance on dosage and administration labeling
Regulatory News
Joanne S. Eglovitch
Biologics/ biosimilars/ vaccines
Compliance
North America
Pharmaceuticals
Regulatory Intelligence/Policy